VFMF - ETF AI Analysis
Top Page
Vanguard U.S. Multifactor ETF (VFMF)
Rating:72Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and in recent months, indicating positive momentum.
Healthy Top Holdings
Many of the largest positions, including companies in technology, energy, and health care, have delivered strong year-to-date results that support the fund’s overall performance.
Moderate, Low-Cost Fees
The expense ratio is relatively low for an actively managed multifactor strategy, helping investors keep more of their returns.
Negative Factors
Heavy U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering very little geographic diversification.
Sector Tilts Toward Financials and Health Care
Large weights in financial and health care stocks mean the fund could be more affected if these sectors face a downturn.
Limited Impact From Individual Winners
Because each holding makes up a small share of the portfolio, even very strong-performing stocks have only a modest effect on overall returns.
VFMF vs. SPDR S&P 500 ETF (SPY)
AUM610.93M
RegionNorth America
Expense Ratio0.18%
Beta0.89
IssuerVanguard
Inception DateFeb 13, 2018
Dividend Yield1.42%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume20,956
30 Day Avg. Volume19,781
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
189.05Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering588
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VFMF Summary
Vanguard U.S. Multifactor ETF (VFMF) is a fund that invests in a wide range of U.S. companies across many sectors, including financials, health care, technology, and energy. It doesn’t track a single index, but instead follows a “multifactor” theme, picking stocks based on traits like value, recent performance, and business strength. Well-known holdings include Merck & Company and Amgen. Someone might invest in VFMF to get diversified exposure to many parts of the U.S. stock market in one fund. A key risk is that its stock prices can rise and fall significantly with the overall market.
How much will it cost me?The Vanguard U.S. Multifactor ETF (VFMF) has an expense ratio of 0.18%, meaning you’ll pay $1.80 per year for every $1,000 invested. This is slightly higher than the average for passively managed ETFs because it uses a multifactor strategy to select stocks, which requires more active management. However, it’s still relatively low compared to actively managed funds.
What would affect this ETF?The Vanguard U.S. Multifactor ETF (VFMF) could benefit from positive trends in the U.S. economy, such as strong consumer spending and technological innovation, which align with its exposure to sectors like Consumer Cyclical and Technology. However, it may face challenges from rising interest rates, which could impact its Financial sector holdings, and economic slowdowns that might affect cyclical industries like Industrials and Energy. Regulatory changes in healthcare or financial services could also influence the performance of its top holdings, such as Gilead Sciences and Wells Fargo.
VFMF Top 10 Holdings
VFMF’s story is less about flashy mega-cap tech and more about a balanced cast of U.S. workhorses. Micron has been a clear bright spot, riding the AI and memory upswing, while ConocoPhillips has added fuel with strong energy momentum. Financials like Bank of New York Mellon are also rising, giving the fund a solid push from the banking side. On the flip side, health care names such as HCA and McKesson have been more mixed lately, occasionally tapping the brakes on an otherwise broadly diversified, U.S.-only portfolio.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Micron | 1.16% | $7.11M | $650.08B | 616.80% | 79 Outperform | |
| Altria Group | 0.93% | $5.70M | $122.59B | 22.62% | 64 Neutral | |
| Qualcomm | 0.88% | $5.36M | $177.47B | 20.75% | 80 Outperform | |
| Alphabet Class A | 0.84% | $5.13M | $4.62T | 133.39% | 85 Outperform | |
| Bank of New York Mellon | 0.83% | $5.05M | $90.52B | 60.48% | 75 Outperform | |
| Bristol-Myers Squibb | 0.82% | $5.02M | $117.17B | 14.62% | 78 Outperform | |
| Conocophillips | 0.82% | $4.99M | $152.18B | 42.58% | 78 Outperform | |
| Newmont Mining | 0.81% | $4.95M | $115.65B | 104.24% | 81 Outperform | |
| Merck & Company | 0.80% | $4.90M | $279.37B | 36.54% | 80 Outperform | |
| Travelers Companies | 0.77% | $4.68M | $64.12B | 13.90% | 78 Outperform |
VFMF Technical Analysis
Positive
―
Price Trends
159.97
Positive
157.93
Positive
149.42
Positive
Market Momentum
2.48
Negative
65.36
Neutral
25.94
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VFMF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 164.89, equal to the 50-day MA of 159.97, and equal to the 200-day MA of 149.42, indicating a bullish trend. The MACD of 2.48 indicates Negative momentum. The RSI at 65.36 is Neutral, neither overbought nor oversold. The STOCH value of 25.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VFMF.
VFMF Peer Comparison
Comparison Results
Performance Comparison
VFMF
Vanguard U.S. Multifactor ETF
169.40
44.23
35.34%
SYLD
Cambria Shareholder Yield ETF
―
―
―
ULTY
YieldMax Ultra Option Income Strategy ETF
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
AVTM
Avantis Total Equity Markets ETF
―
―
―
XCHG
AB US Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents